As part of PSS efforts to provide members with the relevant professional development & upgrading programmes, we have been in contact with some potential overseas tertiary institutions to explore suitable post-basic advancement development programmes.

With just a few more days away from the first ever FAPA Congress to be hosted by PSS in 44 years, come a join colleagues from 25 different countries who will converge in Singapore from 7-10 Nov., 2008.

Check out the following events and notice. Do take note and mark them on your calendar. Thanks very much.

 Here are few brief news related to healthcare & pharmaceutical scenes for your update.

• US Consumer Group Urged FDA to Ban Rosiglitazone
• Sanofi-Aventis Expands Its R&D Presence in China
• US FDA to Establish Footprint Overseas

Biologic agents are a relatively new class of drugs, and according to a report in the October issue of the JAMA, associated safety problems are often identified only at post-approval stages through the post-marketing surveillance system.

The Institute for Safe Medication Practices (ISMP) analyzed and compiled every report submitted to FDA during the first 3 months of the year. The research found 20,745 reports of serious adverse events (SAE) from prescription drugs in the US, a 34% rise compared to last year’s quarterly average. Even more curious, deaths increased from 1,868 to 4,824 over the previous quarter.

• Bill Gates' Rules for Students 

The following jobs/events are currently available. Kindly apply/register directly based on the information provided. Best of luck!